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Improving Response Rates With
Cardiac Resynchronization Therapy*N.A. Mark Estes, III, MDC linical trials evaluating cardiac resynchroni-zation therapy (CRT) have demonstratedimproved heart failure status, quality of
life, exercise capacity, systolic function of the left
ventricle (LV), mortality, and numerous other out-
comes in heart failure patients (1,2). Current guide-
lines recommend CRT for heart failure patients with
LV ejection fraction (EF) <35%, New York Heart Asso-
ciation functional class I to III symptoms on optimal
medical therapy, and QRS duration $120 ms on the
surface electrocardiogram. Although most patients
respond to CRT, up to 30% of patients meeting
implant criteria fail to show clinical beneﬁt. This
rate of CRT nonresponders has been represented as
the “Achilles’ heel” of CRT. Multiple investigations
have focused on techniques of optimizing LV lead
position to improve response rates. Although the
evidence supporting CRT is robust, the inability
to develop proven techniques to optimize LV lead
position and improve outcomes remains a notable
weakness.
Because QRS duration and morphology have been
inclusion criteria for CRT clinical trials, these and
other purely electrical parameters of global and
regional depolarization have been evaluated as pre-
dictors of CRT response (3,4). Patients with left
bundle branch block (LBBB) and more prolonged QRS
durations have better response rates with improved
hemodynamics, clinical outcomes, and LV reverse
remodeling (3). LV electrical delay is considered to be
an important factor in predicting response to CRT (3).
Recent investigations of electrical dyssynchrony, as
evaluated by the time interval between the initial
deﬂection of the surface electrocardiogram QRS and*Editorials published in JACC: Cardiovascular Imaging reﬂect the views of
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Cardiovascular Imaging or the American College of Cardiology.
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consulting fees from Boston Scientiﬁc, St. Jude Medical, and Medtronic.local LV activation at the LV stimulation site (QLV),
indicate a strong and independent association with
reverse remodeling and other outcomes with CRT (4).
In addition to these electrical parameters, the
anatomic position of the LV lead has been demon-
strated to have a profound inﬂuence on clinical
response (5). The lateral or posterolateral branches of
the coronary sinus have most consistently resulted in
restoration of coordinated myocardial contraction (5).
However, even with appropriate anatomic lead
placement, there remains considerable individual
variation in response. A substantial proportion of
patients fail to respond, despite optimization of
electrical and anatomic parameters (5). Both the
location and amount of mechanical dyssynchrony,
reﬂecting distribution and extent of myocardial scar
relative to the LV lead position, have been found to be
important in selecting optimal LV lead position.
Retrospective cardiac magnetic resonance imaging
and single-photon emission computed tomography
(SPECT) studies have demonstrated an unfavorable
outcome after CRT when the LV lead is positioned in
areas with transmural myocardial scar (6,7).
Multiple studies indicate that LV pacing place-
ment might be reﬁned with assessment of LV
regional mechanical dyssynchrony (6,7). The effects
of resynchronization can be optimized when the LV
is paced at the site that is most delayed on the
basis of mechanical rather than anatomic location or
electrical activation (6,7). Preliminary investigations
indicated that pacing the most mechanically-
delayed LV region improves response rates to CRT.
Assessment of mechanical dyssynchrony, identiﬁed
as the latest activated LV myocardial segment, has
been performed by multiple imaging techniques.
These include echocardiography and Doppler tech-
niques, SPECT, cardiac magnetic resonance imaging,
and cardiac computed tomography. Promising re-
sults on CRT outcome were reported in an initial
prospective study evaluating the effect of speckle-
tracking echocardiography to optimize LV lead
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1250placement, but have not been reproduced in larger
studies (6,7).SEE PAGE 1239In this issue of iJACC, Zhou et al. (8) report on a novel
approach to selecting the site of LV pacing by assessing
viable regions of myocardium with late activation (8).
Using a novel technique of 3-dimensional fusion of LV
venous anatomy with ﬂuoroscopic venograms on
SPECT myocardial perfusion images, the investigators
used landmark-based registration and vessel surface
overlay to fuse the venous anatomywith the epicardial
surface (8). The accuracy of the technique was vali-
dated with computed tomography venograms (8).
Thus, the feasibility of this approach to guide LV lead
placement was reported in a small series of patients.
Although the investigators conclude that this tech-
nique is technically accurate and feasible, it is evident
that additional research is needed (8). The data pre-
sented are adequate for validating technical accuracy
and demonstrating feasibility, but the effect of this
technique on response rates to CRT and clinical out-
comes remains to be determined. This study needs
to be conﬁrmed with additional patients and mean-
ingful assessment of clinical outcomes. Prospective
multicenter trials ultimately would be necessary to
fully assess the clinical utility of the technique (8).
This novel technique of optimizing LV lead placement
detailed in this issue, like other electrical, anatomic,
or mechanical techniques, has not met the standards
of evidence-based medicine by demonstrating im-
proved response rates in appropriately-designed clin-
ical trials.
Although the focus on optimizing techniques of LV
lead placement to improve CRT response rates is
appropriate, clinicians and investigators should also
examine the issue of CRT nonresponders from a
broader perspective. Heart failure patients withan LBBB derive substantial clinical beneﬁt from
CRT-deﬁbrillator, with a reduction in heart failure
progression and a reduction in the risk of ventricular
tachyarrhythmias. By contrast, no clinical beneﬁt has
been observed in patients with a non-LBBB QRS
pattern (right bundle-branch block or intraventricular
conduction disturbances). Subgroups of patients with
QRS widths $150 ms consistently demonstrate the
greatest decrease in heart failure events, reduction in
LV volumes, and improvement in LVEF. Females have
considerably higher response rates to CRT than males.
Patients with nonischemic cardiomyopathy respond
more frequently than those with ischemic heart dis-
ease. Patients in sinus rhythm demonstrate response
rates considerably higher than those in atrial ﬁbrilla-
tion. Multiple analyses have concluded that there is a
threshold effect with respect to percent LV pacing.
Patients with 95% LV pacing or more have response
rates that are higher than those pacing <95%. Assess-
ment of ineffective resynchronization from fusion or
pseudo-fusion beats during LV pacing with ambula-
tory monitoring can provide useful information that
allows for improved CRT response rates. Novel tech-
niques of AV optimization, multisite endovascular LV
epicardial pacing, and LV endocardial pacing including
leadless LV pacingmay provide innovative approaches
to improving CRT response rates (9). As investigations
of these and other novel approaches to the “Achilles’
heel” of CRT move forward, clinicians and in-
vestigators should be mindful of the existing robust
evidence related to patient selection and pacing tech-
niques currently known to improve response rates.
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